Perindopril erbumine belongs to the member of angiotensin-converting enzyme inhibitors group used in the treatment of heart failure and hypertension. Asimple and highly sensitive LC-MS method has been developed for the simultaneous determination of three process-related impurities (L-norvaline, L-norvaline ethyl ester HCl, and (S)-indoline-2-carboxylic acid) in perindopril. Samples were separated using 5 mM ammonium formate (A) and acetonitrile/methanol (B) as the mobile phase on a Symmetry C18 column (75 mm × 4.6 mm, 3.5 μm) using gradient elution mode at a flow rate of 0.6 mL/min. The proposed method was validated as per ICH guidelines and can be used for quality testing of perindopril and determining its process-related impurities in pharmaceuticals.
This is a preview of subscription content, log in via an institution to check access.
References
C. Werner, J. Poss and M. Bohm, Drugs, 70(10), 1215 – 1230, (2010).
C.Werner, M. Baumhakel, K. K. Teo, et al., Clin. Res. Cardiol., 97(7), 418 – 431, (2008).
P. J. Anderson, J. A. Critchley, B. Tomlinson and G. Resplandy, Brit. J. Clin. Pharmacol., 39(4), 361 – 368, (1995).
E. Telejko, Curr. Med. Res. Opin., 23(5), 953 – 960, (2007).
M. Medenica, D. Ivanovic, M. Maskovic, et al., J. Pharm. Biomed. Anal., 44(5), 1087 – 109, (2007).
M. Maskovic, Y. Dotsikas, A. Malenovic, et al., J. AOAC. Int., 94(3), 723 – 734, (2011).
H. E. Zaazaa, S. S. Abbas, H. A. Essam, and M. G. El-Bardicy, J. Chromatogr. Sci., 51(6), 533 – 543, (2013).
British Pharmacopoeia. Perindopril Erbumine Tablets Monograph, British Pharmacopoeia, The Stationery Office, London, UK (2014).
Z. Simoncic, R. Roskar, A. Gartner, et al., Int. J. Pharm., 356(1 – 2), 200 – 205, (2008).
H. Jogia, U. Khandelwal, T. Gandhi, et al., J. AOAC. Int., 93(1), 108 – 115, (2010).
M. Gumustas and S. A. Ozkan, J. AOAC. Int., 96(4), 751 – 757, (2013).
A. Prameelarani and C. Balasekaran Sekaran, Int. J. Pharm. Technol. Res., 1, 575 – 578, (2009).
H. H. Dugga, R. Peraman and D. Nayakanti, J. Chromatogr. Sci., 52(4), 315 – 320, (2014).
M. Paczkowska, P. Zalewski, P. Garbacki, et al., Chromatographia, 77(21), 1497 – 1501, (2014).
K. M. Darshana and N. P. Chhagan, Int. J. Pharm. Technol. Res., 2, 411 – 416, (2010).
N. Erk, J. Pharm. Biomed. Anal., 26(1), 43 – 52, (2001).
A. A. Elshanawane, S. M. Mostafa, and M. S. Elgawish, Chromatographia, 67(9), 837 – 840, (2008).
R. Vijayalakshmi, S. Archana and M. Dhanaraju, Asian J. Res. Chem., 3, 571 – 573, (2010).
S. Bouabdallah, H. Trabelsi, M. T. B. Dhia, and N. B. Hamida, Chromatographia, 75(21), 1247 – 1255, (2012).
J. Juddy, P. Blessen and M. Sundarapandian, Int. J. Pharm. Pharmac. Sci., 3, 288 – 293, (2011).
A. I. Patel, C. K. Oza, J. Prajapati, et al., Int. J. Pharm. Bio. Sci., 2, 709 – 715, (2011).
International Conference on Harmonization of Technical Rquirements for Registration of Pharmaceuticals for Human Use (ICH), Q2(R1): Validation of Analytical Procedures: Text and Methodology, Geneva, Switzerland (1994).
Acknowledgments
KSU authors appreciate support of the Deanship of Scientific Research at the King Saud University (KSU) for Research Group RGP-1437 – 003.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kumar, N.S., Sreenivasulu, V., Ramachandra, B. et al. A Stability-Indicating LC-MS Method for Determination of Perindopril and its Process Related Impurities. Pharm Chem J 52, 378–383 (2018). https://doi.org/10.1007/s11094-018-1825-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-018-1825-2